AIP
INMB icon

Ameritas Investment Partners’s INmune Bio INMB Stock Holding History

Ameritas Investment Partners’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Hold
1,196
– – ﹤0.01% 3082
2025
Q4 		$1.87K Hold
1,196
– – ﹤0.01% 3093
2025
Q3 		$2.48K Hold
1,196
– – ﹤0.01% 3110
2025
Q2 		$2.76K Hold
1,196
– – ﹤0.01% 3153
2025
Q1 		$9.34K Hold
1,196
– – ﹤0.01% 2841
2024
Q4 		$5.58K Hold
1,196
– – ﹤0.01% 3013
2024
Q3 		$6.45K Hold
1,196
– – ﹤0.01% 3006
2024
Q2 		$10.5K Buy
+1,196
New +$11.8K ﹤0.01% 2905

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's INMB Position: Q1 2026 in Review

Ameritas Investment Partners held its INmune Bio (INMB) position steady in Q1 2026 at 1,196 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Ameritas Investment Partners first reported a position in INMB in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.5K in Q2 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Ameritas Investment Partners held 1,196 shares of INmune Bio worth $1.35K as of Q1 2026.
  • Ameritas Investment Partners left its INmune Bio share count unchanged in Q1 2026.
  • INmune Bio made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #3082 holding.
  • Ameritas Investment Partners first reported a position in INmune Bio in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's INmune Bio position peaked at $10.5K in Q2 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.